Sabra Health Care REIT Raises FY2024 FFO Guidance from $1.36-1.39 to $1.39-1.40 vs $1.38 Est
Portfolio Pulse from Benzinga Newsdesk
Sabra Health Care REIT has increased its FY2024 FFO guidance from $1.36-1.39 to $1.39-1.40, surpassing the analyst estimate of $1.38.
October 31, 2024 | 8:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sabra Health Care REIT has raised its FY2024 FFO guidance to $1.39-1.40, exceeding the analyst estimate of $1.38, indicating a positive outlook.
The increase in FFO guidance suggests improved financial performance, which is likely to positively impact SBRA's stock price. The new guidance surpasses analyst expectations, indicating strong operational performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100